Sten Wingren
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 30
- Cancer-related Molecular Pathways 10
- HER2/EGFR in Cancer Research 6
-
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 9
- Co-authors
- Bo Nordenskjöld (23 shared papers)Olle Stål (19 shared papers)John Carstensen (18 shared papers)Pia Wegman (12 shared papers)Lambert Skoog (7 shared papers)Thomas Hatschek (7 shared papers)Lars Erik Rutqvist (5 shared papers)Elingarami Sauli (1 shared paper)
In The Last Decade
Sten Wingren
62 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 534
- Pharmacology 289
- Oncology 831
- Pathology and Forensic Medicine 347
- Genetics 460
Countries citing papers authored by Sten Wingren
This map shows the geographic impact of Sten Wingren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sten Wingren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sten Wingren more than expected).
Fields of papers citing papers by Sten Wingren
This network shows the impact of papers produced by Sten Wingren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sten Wingren. The network helps show where Sten Wingren may publish in the future.
Co-authors
The 25 scholars most cited alongside Sten Wingren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 230 | |
| 2 | 1992 | 204 | |
| 3 | 2005 | 186 | |
| 4 | Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. | 1999 | 117 |
| 5 | 1995 | 113 | |
| 6 | 1989 | 74 | |
| 7 | 1989 | 66 | |
| 8 | 2000 | 60 | |
| 9 | 1993 | 57 | |
| 10 | 1994 | 54 | |
| 11 | 2001 | 54 | |
| 12 | 2007 | 53 | |
| 13 | 2014 | 52 | |
| 14 | 2002 | 50 | |
| 15 | 2001 | 48 | |
| 16 | 2005 | 43 | |
| 17 | 1988 | 42 | |
| 18 | 1996 | 37 | |
| 19 | 1995 | 35 | |
| 20 | 1996 | 34 |
About Sten Wingren
Sten Wingren is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 63 papers that have together received 2.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (11 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (10 papers), Breast Cancer Treatment Studies (9 papers), Genetic factors in colorectal cancer (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (6 papers) and Genomics and Chromatin Dynamics (5 papers). The work is most often cited by research in Cancer Research (534 citations), Pharmacology (289 citations), Oncology (831 citations), Pathology and Forensic Medicine (347 citations) and Genetics (460 citations). Sten Wingren has collaborated with scholars based in Sweden, Norway and Ireland. Frequent co-authors include Bo Nordenskjöld, Olle Stål, John Carstensen, Pia Wegman, Lambert Skoog, Thomas Hatschek, Lars Erik Rutqvist, Elingarami Sauli, Xiao‐Feng Sun and Peter Söderkvist. Their work appears in journals such as Acta Oncologica, European Journal of Cancer, British Journal of Cancer, Breast Cancer Research and Treatment and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.